12.18% -0.53

소님 테크놀로지스 (SONM)

개요 뉴스 가격 이력 Financials 토론 예측 주식 분할

Relative Volume:

소님 테크놀로지스 Stock (SONM) Company Profile

Technology (782)

650-378-8100

4445 EASTGATE MALL, SAN DIEGO, TX

최신 SEC 제출 서류

SONM's Discussions on Twitter

Compare SONM vs MSFT, PLTR, ORCL, CRWD, FTNT

주식	가격	시가총액	매출	순이익	현금흐름	주당 순 이익
SONM Dna X Inc	4.10	5.83M	27.40M	-17.12M	-24.99M	-106.89
MSFT Microsoft Corp	506.08	3.83T	318.27B	125.22B	72.92B	16.79
PLTR Palantir Technologies Inc	185.75	455.79B	5.22B	2.29B	2.69B	0.8876
ORCL Oracle Corp	137.73	414.55B	67.36B	17.31B	-23.69B	5.8248
CRWD Crowdstrike Holdings Inc	259.40	258.16B	5.09B	-24.89M	1.43B	-0.0471
FTNT Fortinet Inc	174.72	127.27B	7.11B	1.95B	2.44B	2.5883

소님 테크놀로지스 Stock (SONM) Upgrades & Downgrades

날짜	액션	분석자	등급 변경
2019-10-31	다운그레이드	Oppenheimer	Outperform → Perform
2019-07-18	개시	B. Riley FBR	Buy
2019-07-09	업그레이드	National Securities	Neutral → Buy
2019-06-10	개시	National Securities	Neutral
2019-06-04	개시	Lake Street	Buy
2019-06-04	개시	Oppenheimer	Outperform

소님 테크놀로지스 주식(SONM)의 최신 뉴스

소님 테크놀로지스 (SONM) 재무 분석

소님 테크놀로지스 (SONM)

소님 테크놀로지스 Stock (SONM) Company Profile

Compare SONM vs MSFT, PLTR, ORCL, CRWD, FTNT

소님 테크놀로지스 Stock (SONM) Upgrades & Downgrades

소님 테크놀로지스 주식(SONM)의 최신 뉴스

12 Information Technology Stocks Moving In Thursday's Pre-Market Session - Benzinga

A U.S. DNA platform may resell Virotek's genetic tests beyond eye care. - Stock Titan

Ginkgo Bioworks Holdings, Inc. (DNA) Sees a More Significant Dip Than Broader Market: Some Facts to Know - Yahoo Finance

VEON Ltd. (VEON) Stock Price, News, Quote & History - Yahoo! Finance Canada

VEON Ltd. (VEON) stock price, news, quote and history - Yahoo Finance UK

X-Chem Announces Phase 3 Milestone in Collaboration with Relay Therapeutics - Yahoo Finance

How DNA's Double Helix Structure Was Discovered - Britannica

Up to $17.5M awarded to Ginkgo for medicines made for one patient - Stock Titan

Press Release Service: Researchers Gain Faster Access to Complex DNA as Integrated DNA Technologies and Ansa Biotechnologies Expand Ordering Platform - CRISPR Medicine News

Sonim Technologies Maintains Nasdaq Compliance Amid Monitoring Period - The Globe and Mail

DNA regained Nasdaq equity compliance but faces one-year mandatory monitor - TradingView

SONM Q3 2024 Earnings: Loss Narrower Than Expected, Shares Rise 5.8%Profit Recovery Report - vinanet.vn

Applied DNA Sciences Inc. (APDN) Key Financial Ratios – Valuation, Profitability & More - Value Research

Sonim Technologies Adopts Cash-Based Director Compensation Structure - The Globe and Mail

DNA awards Substitute Cash Grants to board including CEO Mike Mulica - TradingView

DNA X (SONM) turns to cash after equity plan runs out of shares - Stock Titan

Restriction-enzyme DNA fingerprinting method explained - britannica.com

Ginkgo Bioworks (DNA) CFO logs 743 RSU vesting, tax sale - Stock Titan

DNA X: Q2 Earnings Snapshot - AOL.com

DNA X, Inc. Reports Second Quarter 2026 Financial Results - The Manila Times

DNA X Q2 EPS improves to $(0.91) from $(14.15) YoY - scanx.trade

DNA X, Inc. 2Q 2026: Revenue $0 EPS $(0.92) — 10-Q Summary - TradingView

SONM: Net income surged to $5.1M as the company pivoted to crypto trading and raised $5M in new capital - TradingView

DNA X (Nasdaq: SONM) profits from phone sale while crypto platform is in the red - Stock Titan

C&F Financial Corporation Announces Quarterly Dividend - The Manila Times

Beam Global Reports Second Quarter 2026 Operating Results - The Manila Times

VVC Exploration Corporation Files Annual Financial Statements - The Manila Times

DNA X raised $5 million after its quarter ended, while its trading platform had no revenue - Stock Titan

DNA (SONM) Quarter in Focus: The Bottom-Line Figure Outpaces Its Comparison in the Latest Session; Market Reaction: The Stock Ends Down 0.60% in Latest TradingGuidance Update - vinanet.vn

12 Information Technology Stocks Moving In Monday's After-Market Session - Benzinga

Aon plc (AON) Holds Near $355.83 as Insurance Broker Consolidates Between Support and ResistanceHigh Volume Node - Vinanet

Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) Analysts Just Slashed This Year's Revenue Estimates By 22% - simplywall.st

Sonim Technologies delays quarterly filing amid consolidation - TipRanks

DNA X, Inc. (SONM) delays Q2 2026 filing but projects smaller net loss - Stock Titan

SONM Q2'26 Earnings: EPS estimate is 5.22 USD - TradingView

Creative Realities, Inc. (CREX) Stock Price, News, Quote & History - finance.yahoo.com

DNA X, Inc. (SONM) raises $2.5M and targets Nasdaq equity rule compliance - Stock Titan

DNA X, Inc. (SONM) investor Lytton discloses 6.8% stake in latest 13G/A - Stock Titan

DNA X Inc. (SONM) Holds Flat at $3.56 as Range-Bound Trading PersistsChannel Breakout - vinanet.vn

Integrated DNA Technologies Scientists Set New Performance Benchmark for CRISPR Off-Target Nomination - Yahoo Finance

Star Wars Zero Company is a very safe XCOM descendant, but its most interesting parts are found in its Midnight Suns DNA - PC Gamer

Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) Shares Slammed 36% But Getting In Cheap Might Be Difficult Regardless - 富途牛牛

SONM Q3 2024 Earnings: Narrower-Than-Expected Loss Fails to Lift SharesEarnings Beat Streak - dars.gov.et

Ginkgo Bioworks Holdings, Inc. 2026 Q2ResultsEarnings Call Presentation (NYSE:DNA) 2026-08-06 - Seeking Alpha

DNA X Inc. (SONM) Slips 1.69% as Shares Test Key Support at $3.60RSI Overbought Alerts - careplusvn.com

Token Talk Inc. (DNAX) stock price, news, quote and history - Yahoo Finance UK

Ginkgo Bioworks (NYSE: DNA) plans Q2 2026 results presentation and Q&A - Stock Titan

Ginkgo Bioworks (NYSE: DNA) awards RSUs to 10% owner - stocktitan.net

DNA X, Inc. Revenue Breakdown – NASDAQ:SONM - TradingView

YD Bio and EG BioMed Conclude Successful Exhibition at BIO Asia-Taiwan 2026, Highlighting Innovations in Ophthalmology, Oncology Diagnostics, and Clinical Services - The Manila Times

12 Information Technology Stocks Moving In Monday's Pre-Market Session - Benzinga

소님 테크놀로지스 (SONM) 재무 분석

매출

순이익

현금흐름

주당 순 이익

SONM과 유사한 종목